Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
To create leading company developing medicines targeting metalloenzymes
All claims against the company in the litigation have now been dismissed.
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Subscribe To Our Newsletter & Stay Updated
